An act relating to maintaining patient access to animal-derived thyroid medications
Read first time and referred to the Committee on Health Care
Summary
The measure orders the Office of Professional Regulation, together with the Department of Financial Regulation and relevant stakeholders, to explore ways to maintain access to animal‑derived thyroid medications such as desiccated thyroid extract. It requires the agency to put into place any feasible solutions that do not need new legislation and to submit a report with recommendations to the legislature by January 15, 2027. The goal is to help patients who find these drugs more effective or better tolerated than synthetic alternatives.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when H 676 changes status, plus AI-powered summaries and stage predictions.
Sign up free